scholarly article | Q13442814 |
P2093 | author name string | Ken Arai | |
Eng H Lo | |||
Klaus van Leyen | |||
Brian J Lee | |||
Yasuhiro Egi | |||
P2860 | cites work | Effect of MCI-186 on brain edema in rats | Q44710629 |
Free radical scavenger, edaravone, in stroke with internal carotid artery occlusion | Q44921869 | ||
Edaravone, a novel radical scavenger, inhibits oxidative modification of low-density lipoprotein (LDL) and reverses oxidized LDL-mediated reduction in the expression of endothelial nitric oxide synthase | Q45273958 | ||
Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain | Q46164241 | ||
Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator | Q46190589 | ||
Edaravone protects against MPP+ -induced cytotoxicity in rat primary cultured astrocytes via inhibition of mitochondrial apoptotic pathway | Q46471698 | ||
Anti-apoptotic and neuroprotective effects of edaravone following transient focal ischemia in rats | Q46514766 | ||
Edaravone prevents iNOS expression by inhibiting its promoter transactivation and mRNA stability in cytokine-stimulated hepatocytes | Q46851342 | ||
Comparative effects of alpha-tocopherol and gamma-tocotrienol against hydrogen peroxide induced apoptosis on primary-cultured astrocytes | Q46915949 | ||
Stroke and neurovascular protection | Q46935433 | ||
Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. | Q48162562 | ||
Hydrogen peroxide-induced apoptosis mediated by p53 protein in glial cells | Q48304321 | ||
MCI-186 (3-methyl-1-phenyl-2-pyrazolin-5-one) attenuated simulated ischemia/reperfusion injury in cultured rat hippocampal cells | Q48457955 | ||
Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia | Q48658567 | ||
Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. | Q48719184 | ||
Molecular adaptation of vascular endothelial cells to oxidative stress. | Q50784512 | ||
Nitric oxide-induced apoptosis in cultured rat astrocytes: protection by edaravone, a radical scavenger | Q80600933 | ||
NXY-059 for the treatment of acute ischemic stroke | Q80768385 | ||
SAINT-I worked, but the neuroprotectant is not NXY-059 | Q80838619 | ||
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons | Q21262040 | ||
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases | Q28269333 | ||
Neurovascular regulation in the normal brain and in Alzheimer's disease | Q29619659 | ||
Novel lipoxygenase inhibitors as neuroprotective reagents | Q33303894 | ||
Thrombolysis in acute ischemic stroke: controlled trials and clinical experience | Q33758215 | ||
Reactive oxygen radicals in signaling and damage in the ischemic brain | Q33930675 | ||
Neuroprotective effects of edaravone: a novel free radical scavenger in cerebrovascular injury. | Q33997543 | ||
Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials | Q34617625 | ||
Mechanisms, challenges and opportunities in stroke | Q35120144 | ||
Cerebral tissue oxygenation and oxidative brain injury during ischemia and reperfusion | Q36664577 | ||
Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons. | Q36677211 | ||
Translational research in stroke: taking advances in the pathophysiology and treatment of stroke from the experimental setting to clinical trials. | Q36705446 | ||
Cell-cell signaling in the neurovascular unit | Q36801092 | ||
Life after cerovive: a personal perspective on ischemic neuroprotection in the post-NXY-059 era. | Q36810934 | ||
Dysfunctional cell-cell signaling in the neurovascular unit as a paradigm for central nervous system disease | Q37017486 | ||
Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival | Q37184726 | ||
An oligovascular niche: cerebral endothelial cells promote the survival and proliferation of oligodendrocyte precursor cells | Q37361396 | ||
Apoptotic mechanisms after cerebral ischemia | Q37381350 | ||
Mechanism of glutamate-induced neurotoxicity in HT22 mouse hippocampal cells | Q39828570 | ||
A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. | Q41096149 | ||
A novel purification method for CNS projection neurons leads to the identification of brain vascular cells as a source of trophic support for corticospinal motor neurons | Q41904734 | ||
Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger | Q41968726 | ||
Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters | Q44418044 | ||
Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes | Q44536960 | ||
P921 | main subject | edaravone | Q335099 |
P304 | page(s) | 22-27 | |
P577 | publication date | 2009-10-17 | |
P1433 | published in | Brain Research | Q4955782 |
P1476 | title | Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro | |
P478 | volume | 1307 |
Q33938450 | A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy? |
Q39427640 | A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model |
Q37490657 | A novel method for inducing focal ischemia in vitro |
Q33748058 | A radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusion |
Q47782666 | A safety analysis of edaravone (MCI-186) during the first six cycles (24 weeks) of amyotrophic lateral sclerosis (ALS) therapy from the double-blind period in three randomized, placebo-controlled studies |
Q30844551 | A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials |
Q102054034 | ALS motor neurons exhibit hallmark metabolic defects that are rescued by SIRT3 activation |
Q37108311 | Analysis of treatment effect of urinary kallidinogenase combined with edaravone on massive cerebral infarction |
Q34256876 | Changes in cerebrospinal fluid biomarkers in human herpesvirus-6-associated acute encephalopathy/febrile seizures. |
Q47782687 | Edaravone and its clinical development for amyotrophic lateral sclerosis |
Q47802895 | Edaravone attenuates oxidative stress induced by chronic cerebral hypoperfusion injury: role of ERK/Nrf2/HO-1 signaling pathway |
Q38154741 | Edaravone improves functional and structural outcomes in animal models of focal cerebral ischemia: a systematic review |
Q39173214 | Edaravone injection reverses learning and memory deficits in a rat model of vascular dementia |
Q38847362 | Edaravone leads to proteome changes indicative of neuronal cell protection in response to oxidative stress |
Q40898682 | Edaravone offers neuroprotection for acute diabetic stroke patients |
Q45846630 | Edaravone offers neuroprotection in a diabetic stroke model via inhibition of endoplasmic reticulum stress |
Q34412765 | Edaravone promotes functional recovery after mechanical peripheral nerve injury |
Q35181567 | Edaravone protect against retinal damage in streptozotocin-induced diabetic mice. |
Q36649004 | Effects of edaravone on muscle atrophy and locomotor function in patients with ischemic stroke: a randomized controlled pilot study |
Q34769939 | Free radical scavenger, edaravone, reduces the lesion size of lacunar infarction in human brain ischemic stroke |
Q47700268 | How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis? |
Q36913914 | Lipoxygenase: an emerging target for stroke therapy |
Q28393202 | Neuroinflammation and cerebrovascular disease in old age: a translational medicine perspective |
Q38108307 | Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction |
Q38202292 | Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia |
Q37701407 | Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice |
Q30968894 | Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection |
Q91774684 | Protective Effect of Edaravone on Cyclophosphamide Induced Oxidative Stress and Neurotoxicity in Rats |
Q50034037 | Protective effects of a radical scavenger edaravone on oligodendrocyte precursor cells against oxidative stress. |
Q28539510 | Synergy of combined tPA-edaravone therapy in experimental thrombotic stroke |
Q92343944 | Synthesis, Characterization and Antioxidant Properties of a New Lipophilic Derivative of Edaravone |
Q37885608 | Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. |